Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Cataract & MIGS · Massachusetts | Cataract & MIGS · New York | |
|---|---|---|
| Surgeons, 2024 | 256 | 588 |
| Medicare fee-for-service cases | 48,337 | 82,565 |
| Growth since 2019 (Medicare FFS) | +1.2%/yr | −2.7%/yr |
| Forecast cases (Medicare FFS) | 55,500 in 2030 | 85,900 in 2030 |
| Forecast growth | +2.3%/yr to 2030 | +0.7%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 50.4 | 44.5 |
| Medicare Advantage share | 39% | 57% |
| Out of hospital | 83% (+3 pts since 2019) | 75% (+9 pts since 2019) |
| Cases per surgeon | 189 | 140 |
| Top 10 surgeons' share | 17% | 9% |
| Surgeons growing | 88 | 187 |
| New since the base year | 38 | 76 |
| Likely to stop billing it | 12 by 2026 | 40 by 2026 |
| Forecast miss, 1 year (procedure) | 7% | 7% |
| Company payments per surgeon | $798 | $1,562 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.